William Blair & Company’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

William Blair & Company’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,328,132	Closed	-$51.5M	–	2264
2015 Q1	$51.5M	Sell	1,328,132 -313,761	-19%	-$12.1M	0.08%	324
2014 Q4	$55.3M	Sell	1,641,893 -646,648	-28%	-$22.8M	0.09%	303
2014 Q3	$80.1M	Buy	2,288,541 +255,093	+13%	+$8.74M	0.14%	215
2014 Q2	$66.8M	Sell	2,033,448 -780,453	-28%	-$26.7M	0.11%	260
2014 Q1	$104M	Buy	2,813,901 +200,495	+8%	+$7.36M	0.17%	183
2013 Q4	$100M	Buy	2,613,406 +804,728	+44%	+$25.4M	0.17%	183
2013 Q3	$49.6M	Buy	1,808,678 +96,043	+6%	+$2.28M	0.09%	329
2013 Q2	$36M	Buy	+1,712,635	New	+$33.4M	0.07%	387

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

William Blair & Company's WX Position: Q2 2015 in Review

William Blair & Company sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 1,328,132 shares — an estimated $51.5M sold.

William Blair & Company first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $104M in Q1 2014. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

William Blair & Company reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
William Blair & Company sold 1,328,132 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $51.5M.
William Blair & Company first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
William Blair & Company's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $104M in Q1 2014.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on William Blair & Company's 13F filing for Q2 2015, filed 3 Aug 2015.